XML 41 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Feb. 28, 2013
STOCKHOLDERS' EQUITY [Abstract]  
Schedule of Stock Options

The following table summarizes stock option activity for fiscal years 2013, 2012 and 2011 (options in thousands):

          Weighted
    Number of   Average
    Options   Exercise Price
Outstanding at February 28, 2010   2,023     $ 5.82
             
Granted   186       2.34
Exercised   -       -
Forfeited or expired   (101 )     19.23
Outstanding at February 28, 2011   2,108       4.87
             
Granted   163       3.42
Exercised   (16 )     1.68
Forfeited or expired   (92 )     4.98
Outstanding at February 28, 2012   2,163       4.78
             
Granted   84       7.01
Exercised   (466 )     2.78
Forfeited or expired   (125 )     3.90
Outstanding at February 28, 2013   1,656     $ 5.53
             
Exercisable at February 28, 2013   1,377     $ 5.82
Schedule of Restricted Stock and RSUs

Changes in the Company's outstanding restricted stock shares and RSUs during fiscal years 2013, 2012 and 2011 were as follows (shares and RSUs in thousands):

          Weighted
    Number of   Average Grant
    Shares   Date Fair
    and RSUs   Value
Outstanding at February 28, 2010   1,784     $ 2.06
             
Granted   863       2.34
Vested   (544 )     2.15
Forfeited   (58 )     1.78
Outstanding at February 28, 2011   2,045       2.16
             
Granted   762       3.59
Vested   (819 )     2.21
Forfeited   (59 )     1.99
Outstanding at February 28, 2012   1,929       2.71
             
Granted   440       7.50
Vested   (916 )     2.53
Forfeited   (115 )     2.85
Outstanding at February 28, 2013   1,338     $ 4.40
Schedule of Stock Option Valuation Assumptions
    Year Ended February 28,
Black-Scholes Valuation Assumptions     2013   2012   2011
Expected life (years) (1)   6   6   6
Expected volatility (2)   63%   73%   74%
Risk-free interest rates (3)   0.8%   1.9%   2.1%
Expected dividend yield   0%   0%   0%
Schedule of Financial Statement Allocation of Stock-based Compensation Expense
Year Ended February 28,
    2013   2012   2011
Cost of revenues   $ 136   $ 100   $ 151
Research and development     450     388     339
Selling     252     204     209
General and administrative     2,072     1,683     1,410
    $ 2,910   $ 2,375   $ 2,109